On Jan. 13, 2026, The American Cancer Society (ACS) released Cancer Statistics, 2026, the organization’s annual report on cancer facts and trends. The findings show, for…
On Jul. 24, 2025, University of Alberta (UA) researchers announced they have harnessed the power of artificial intelligence…
On Jun. 13, 2025, people in England will become the first in the world to receive belantamab mafodotin…
On Sep. 4, 2024, an international consortium led by scientists from Uppsala University in Sweden reported that the…
On Sep. 3, 2024, the National Cancer Institute (NCI) announced that the latest Cancer Trends Progress Report included…
On Dec. 19, 2023, a research team led by Rice University reported they found that the atoms of…
On May 1, 2023, an Oregon Health Sciences University (OHSU) dermatologist and a multi-disciplinary team confirmed that a…
On Apr. 18, 2023, the U.S. Preventive Services Task Force (USPSTF) published a final recommendation statement on screening…
On Jul. 8, 2021, the National Institutes of Health (NIH) reported that the overall cancer death rates continue…
On Apr. 6, 2020, the National Cancer Institute awarded of $14.54 million to Roswell Park Comprehensive Cancer Center…
On Mar. 19, 2020, The UArizona Cancer Center announced it was awarded a five-year, $6.9 million prestigious Program…
On Mar. 13, 2019, Dr. Liang Lie of Mason Cancer Center’s Hormel Institute received a $100,000 two year…
On Nov. 10, 2015, Genentech announed that its drug Cotellic (cobimetinib) was approved by the U.S. Food and…
On Aug. 17, 2011, Genentech announced that Elborafﾮ (vemurafenib) was approved by the FDA for the treatment of…
On Aug. 16, 2011, the U.S. Food and Drug Administration (FDA) approved vemurafenib tablets (Zelboraf, Hoffmann-LaRoche Inc.) for…
On Oct. 26, 2009, the Smilow Cancer Hospital opened for patient care with María Rosa Menocal, a Yale…
On Oct. 10, 2006, Yale Cancer Center was awarded a SPORE (Specialized Programs of Research Excellence) grant for…
On Sept. 1, 2006, National Cancer Institute (NCI) researchers developed a new model for estimating the 5-year risk…
On Jun. 29, 2006, researchers at the National Cancer Institute have identified a link between inherited and acquired…
On Sept. 19, 2002, a new approach to cancer treatment that replaced a patient’s immune system with cancer-fighting…
On May 22, 1989, Dr. Steven A. Rosenberg and his team at the National Cancer Institute (NCI) performed…
In 1987, The Cold Spring Harbor Laboratory (CSHL) Cancer Center received National Cancer Institute (NCI) designation. CSHL researchers…
On Jun. 5, 1986, the U.S. Food and Drug Administration (FDA) approved Hoffmann La Roche’s Interferon initially for…